2019-09-26 |
Oncopeptides AB |
Fredrik Lehmann |
Head of Research and CMC |
|
Förvärv |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
33 000 |
Antal |
0,11 |
SEK |
Historik |
Anmälan
|
2019-09-26 |
Oncopeptides AB |
Fredrik Lehmann |
Head of Research and CMC |
|
Avyttring |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
18 648 |
Antal |
124,80 |
SEK |
Historik |
Anmälan
|
2019-09-25 |
Oncopeptides AB |
Stig Anders Jacob Lindberg |
VD |
|
Förvärv |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
805 500 |
Antal |
0,11 |
SEK |
|
Anmälan
|
2019-09-25 |
Oncopeptides AB |
Stig Anders Jacob Lindberg |
VD |
|
Avyttring |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
480 078 |
Antal |
124,80 |
SEK |
|
Anmälan
|
2019-09-25 |
Oncopeptides AB |
Fredrik Lehmann |
Head of Research and CMC |
|
Tilldelning |
Employee option program 2012/2019 i Oncopeptides AB (publ) |
Option |
|
2019-09-24 |
33 000 |
Antal |
0,11 |
SEK |
Reviderad |
Anmälan
|
2019-09-25 |
Oncopeptides AB |
Fredrik Lehmann |
Head of Research and CMC |
|
Avyttring |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
18 648 |
Antal |
124,80 |
SEK |
Reviderad |
Anmälan
|
2019-09-24 |
Oncopeptides AB |
Johan Harmenberg |
Chief Medical Officer |
|
Tilldelning |
Employee Option Program 2012/2019 |
Option |
|
2019-09-24 |
120 600 |
Antal |
0,11 |
SEK |
|
Anmälan
|
2019-09-24 |
Oncopeptides AB |
Johan Harmenberg |
Chief Medical Officer |
|
Avyttring |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
67 536 |
Antal |
124,80 |
SEK |
|
Anmälan
|
2019-09-24 |
Oncopeptides AB |
Eva Sabina Marianne Nordström |
Vice VD |
|
Avyttring |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-24 |
30 000 |
Antal |
124,80 |
SEK |
|
Anmälan
|
2019-09-18 |
Oncopeptides AB publ. |
Per Wold-Olsen |
Chairman of the Board |
|
Förvärv |
Oncopeptides AB |
Aktie |
SE0009414576 |
2019-09-17 |
10 000 |
Antal |
130,50 |
SEK |
|
Anmälan
|